Rheumatoid Arthritis: KOL Insight

Rheumatoid Arthritis: KOL Insight

LONDON, April 13, 2016 /PRNewswire/ — Key opinion leaders (KOLs) say Rheumatoid Arthritis (RA) treatment is in for a shakeup thanks to anti-TNF biosimilars, new JAK inhibitors, and in the longer-term, other innovative pipeline drugs. Good news for …

(Visited 3 times, 1 visits today)
1
Like
Save

Comments

Write a comment